Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review

CLA Navarro, JAA Damen, T Takada, SWJ Nijman… - bmj, 2021 - bmj.com
Objective To assess the methodological quality of studies on prediction models developed
using machine learning techniques across all medical specialties. Design Systematic …

External validation of prognostic models: what, why, how, when and where?

CL Ramspek, KJ Jager, FW Dekker… - Clinical Kidney …, 2021 - academic.oup.com
Prognostic models that aim to improve the prediction of clinical events, individualized
treatment and decision-making are increasingly being developed and published. However …

Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on …

GS Collins, P Dhiman, CLA Navarro, J Ma, L Hooft… - BMJ open, 2021 - bmjopen.bmj.com
Introduction The Transparent Reporting of a multivariable prediction model of Individual
Prognosis Or Diagnosis (TRIPOD) statement and the Prediction model Risk Of Bias …

The role of artificial intelligence in early cancer diagnosis

B Hunter, S Hindocha, RW Lee - Cancers, 2022 - mdpi.com
Simple Summary Diagnosing cancer at an early stage increases the chance of performing
effective treatment in many tumour groups. Key approaches include screening patients who …

Calibration: the Achilles heel of predictive analytics

B Van Calster, DJ McLernon, M Van Smeden… - BMC medicine, 2019 - Springer
Background The assessment of calibration performance of risk prediction models based on
regression or more flexible machine learning algorithms receives little attention. Main text …

Minimum sample size for external validation of a clinical prediction model with a binary outcome

RD Riley, TPA Debray, GS Collins, L Archer… - Statistics in …, 2021 - Wiley Online Library
In prediction model research, external validation is needed to examine an existing model's
performance using data independent to that for model development. Current external …

PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration

KGM Moons, RF Wolff, RD Riley, PF Whiting… - Annals of internal …, 2019 - acpjournals.org
Prediction models in health care use predictors to estimate for an individual the probability
that a condition or disease is already present (diagnostic model) or will occur in the future …

Reporting of artificial intelligence prediction models

GS Collins, KGM Moons - The Lancet, 2019 - thelancet.com
For more on theTRIPOD statement see https://www. tripodstatement. org technology, and
intelligent monitoring. Behind the digital health revolution are also methodological …

A guide to systematic review and meta-analysis of prognostic factor studies

RD Riley, KGM Moons, KIE Snell, J Ensor, L Hooft… - bmj, 2019 - bmj.com
Prognostic factors are associated with the risk of future health outcomes in individuals with a
particular health condition or some clinical start point (eg, a particular diagnosis). Research …

Topical drug delivery: History, percutaneous absorption, and product development

MS Roberts, HS Cheruvu, SE Mangion… - Advanced drug delivery …, 2021 - Elsevier
Topical products, widely used to manage skin conditions, have evolved from simple potions
to sophisticated delivery systems. Their development has been facilitated by advances in …